| Year |
Citation |
Score |
| 2017 |
Hoang VT, Yan TJ, Cavanaugh JE, Flaherty PT, Beckman BS, Burow ME. MEK5-ERK5 Signaling in Cancer: Implications for Targeted Therapy. Cancer Letters. PMID 28153789 DOI: 10.1016/J.Canlet.2017.01.034 |
0.479 |
|
| 2014 |
Gestaut MM, Antoon JW, Burow ME, Beckman BS. Inhibition of sphingosine kinase-2 ablates androgen resistant prostate cancer proliferation and survival. Pharmacological Reports : Pr. 66: 174-8. PMID 24905325 DOI: 10.1016/J.Pharep.2013.08.014 |
0.627 |
|
| 2014 |
Ponnapakam AP, Liu J, Bhinge KN, Drew BA, Wang TL, Antoon JW, Nguyen TT, Dupart PS, Wang Y, Zhao M, Liu YY, Foroozesh M, Beckman BS. 3-Ketone-4,6-diene ceramide analogs exclusively induce apoptosis in chemo-resistant cancer cells. Bioorganic & Medicinal Chemistry. 22: 1412-20. PMID 24457089 DOI: 10.1016/J.Bmc.2013.12.065 |
0.685 |
|
| 2014 |
Martin EC, Elliott S, Rhodes LV, Antoon JW, Fewell C, Zhu Y, Driver JL, Jodari-Karimi M, Taylor CW, Flemington EK, Beckman BS, Collins-Burow BM, Burow ME. Preferential star strand biogenesis of pre-miR-24-2 targets PKC-alpha and suppresses cell survival in MCF-7 breast cancer cells. Molecular Carcinogenesis. 53: 38-48. PMID 22911661 DOI: 10.1002/Mc.21946 |
0.618 |
|
| 2013 |
White MD, Chan L, Antoon JW, Beckman BS. Targeting ovarian cancer and chemoresistance through selective inhibition of sphingosine kinase-2 with ABC294640. Anticancer Research. 33: 3573-9. PMID 24023282 |
0.684 |
|
| 2013 |
Antoon JW, Martin EC, Lai R, Salvo VA, Tang Y, Nitzchke AM, Elliott S, Nam SY, Xiong W, Rhodes LV, Collins-Burow B, David O, Wang G, Shan B, Beckman BS, et al. MEK5/ERK5 signaling suppresses estrogen receptor expression and promotes hormone-independent tumorigenesis. Plos One. 8: e69291. PMID 23950888 DOI: 10.1371/Journal.Pone.0069291 |
0.74 |
|
| 2013 |
Liu J, Beckman BS, Foroozesh M. A review of ceramide analogs as potential anticancer agents. Future Medicinal Chemistry. 5: 1405-21. PMID 23919551 DOI: 10.4155/Fmc.13.107 |
0.417 |
|
| 2012 |
Antoon JW, White MD, Driver JL, Burow ME, Beckman BS. Sphingosine kinase isoforms as a therapeutic target in endocrine therapy resistant luminal and basal-A breast cancer. Experimental Biology and Medicine (Maywood, N.J.). 237: 832-44. PMID 22859737 DOI: 10.1258/Ebm.2012.012028 |
0.717 |
|
| 2012 |
Antoon JW, Lai R, Struckhoff AP, Nitschke AM, Elliott S, Martin EC, Rhodes LV, Yoon NS, Salvo VA, Shan B, Beckman BS, Nephew KP, Burow ME. Altered death receptor signaling promotes epithelial-to-mesenchymal transition and acquired chemoresistance. Scientific Reports. 2: 539. PMID 22844580 DOI: 10.1038/Srep00539 |
0.698 |
|
| 2012 |
Collins-Burow BM, Antoon JW, Frigo DE, Elliott S, Weldon CB, Boue SM, Beckman BS, Curiel TJ, Alam J, McLachlan JA, Burow ME. Antiestrogenic activity of flavonoid phytochemicals mediated via the c-Jun N-terminal protein kinase pathway. Cell-type specific regulation of estrogen receptor alpha. The Journal of Steroid Biochemistry and Molecular Biology. 132: 186-93. PMID 22634477 DOI: 10.1016/J.Jsbmb.2012.05.004 |
0.779 |
|
| 2012 |
Bratton MR, Antoon JW, Duong BN, Frigo DE, Tilghman S, Collins-Burow BM, Elliott S, Tang Y, Melnik LI, Lai L, Alam J, Beckman BS, Hill SM, Rowan BG, McLachlan JA, et al. Gαo potentiates estrogen receptor α activity via the ERK signaling pathway. The Journal of Endocrinology. 214: 45-54. PMID 22562654 DOI: 10.1530/Joe-12-0097 |
0.672 |
|
| 2012 |
Antoon JW, White MD, Burow ME, Beckman BS. Dual inhibition of sphingosine kinase isoforms ablates TNF-induced drug resistance. Oncology Reports. 27: 1779-86. PMID 22469881 DOI: 10.3892/Or.2012.1743 |
0.722 |
|
| 2012 |
Antoon JW, Beckman BS. Anti-proliferative effects of the novel ceramide analog (S)-2-(benzylideneamino)-3-hydroxy-N-tetrade-cylpropanamide in chemoresistant cancer. Bioorganic & Medicinal Chemistry Letters. 22: 2624-8. PMID 22366655 DOI: 10.1016/J.Bmcl.2012.01.087 |
0.674 |
|
| 2012 |
Walker CH, Drew BA, Antoon JW, Kalueff AV, Beckman BS. Neurocognitive effects of chemotherapy and endocrine therapies in the treatment of breast cancer: recent perspectives. Cancer Investigation. 30: 135-48. PMID 22250588 DOI: 10.3109/07357907.2011.636116 |
0.654 |
|
| 2012 |
Drew BA, Burow ME, Beckman BS. MEK5/ERK5 pathway: the first fifteen years. Biochimica Et Biophysica Acta. 1825: 37-48. PMID 22020294 DOI: 10.1016/J.Bbcan.2011.10.002 |
0.449 |
|
| 2011 |
Antoon JW, Meacham WD, Bratton MR, Slaughter EM, Rhodes LV, Ashe HB, Wiese TE, Burow ME, Beckman BS. Pharmacological inhibition of sphingosine kinase isoforms alters estrogen receptor signaling in human breast cancer Journal of Molecular Endocrinology. 46: 205-216. PMID 21321095 DOI: 10.1530/Jme-10-0116 |
0.726 |
|
| 2011 |
Antoon JW, Beckman BS. Sphingosine kinase: a promising cancer therapeutic target. Cancer Biology & Therapy. 11: 647-50. PMID 21307640 DOI: 10.4161/Cbt.11.7.14921 |
0.632 |
|
| 2011 |
Antoon JW, White MD, Slaughter EM, Driver JL, Khalili HS, Elliott S, Smith CD, Burow ME, Beckman BS. Targeting NFĸB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2. Cancer Biology & Therapy. 11: 678-89. PMID 21307639 DOI: 10.4161/Cbt.11.7.14903 |
0.736 |
|
| 2011 |
Rhodes LV, Short SP, Neel NF, Salvo VA, Zhu Y, Elliott S, Wei Y, Yu D, Sun M, Muir SE, Fonseca JP, Bratton MR, Segar C, Tilghman SL, Sobolik-Delmaire T, ... ... Beckman BS, et al. Cytokine receptor CXCR4 mediates estrogen-independent tumorigenesis, metastasis, and resistance to endocrine therapy in human breast cancer. Cancer Research. 71: 603-13. PMID 21123450 DOI: 10.1158/0008-5472.Can-10-3185 |
0.537 |
|
| 2011 |
Ponnapakkam A, Beckman B, Foroozesh M. Abstract A32: Novel ceramide analogs induce apoptosis in chemoresistant breast cancer. Molecular Cancer Therapeutics. 10. DOI: 10.1158/1535-7163.Targ-11-A32 |
0.512 |
|
| 2010 |
Rhodes LV, Antoon JW, Muir SE, Elliott S, Beckman BS, Burow ME. Effects of human mesenchymal stem cells on ER-positive human breast carcinoma cells mediated through ER-SDF-1/CXCR4 crosstalk. Molecular Cancer. 9: 295. PMID 21087507 DOI: 10.1186/1476-4598-9-295 |
0.672 |
|
| 2010 |
Antoon JW, White MD, Meacham WD, Slaughter EM, Muir SE, Elliott S, Rhodes LV, Ashe HB, Wiese TE, Smith CD, Burow ME, Beckman BS. Antiestrogenic effects of the novel sphingosine kinase-2 inhibitor ABC294640. Endocrinology. 151: 5124-35. PMID 20861237 DOI: 10.1210/En.2010-0420 |
0.727 |
|
| 2010 |
Bratton MR, Duong BN, Elliott S, Weldon CB, Beckman BS, McLachlan JA, Burow ME. Regulation of ERalpha-mediated transcription of Bcl-2 by PI3K-AKT crosstalk: implications for breast cancer cell survival. International Journal of Oncology. 37: 541-50. PMID 20664923 DOI: 10.3892/Ijo_00000703 |
0.718 |
|
| 2010 |
Liu J, Antoon JW, Ponnapakkam A, Beckman BS, Foroozesh M. Novel anti-viability ceramide analogs: design, synthesis, and structure-activity relationship studies of substituted (S)-2-(benzylideneamino)-3-hydroxy-N-tetradecylpropanamides. Bioorganic & Medicinal Chemistry. 18: 5316-22. PMID 20639111 DOI: 10.1016/J.Bmc.2010.05.044 |
0.622 |
|
| 2010 |
Struckhoff AP, Patel B, Beckman BS. Inhibition of p53 sensitizes MCF-7 cells to ceramide treatment. International Journal of Oncology. 37: 21-30. PMID 20514393 DOI: 10.3892/Ijo_00000649 |
0.479 |
|
| 2010 |
Payton-Stewart F, Khupse RS, Boué SM, Elliott S, Zimmermann MC, Skripnikova EV, Ashe H, Tilghman SL, Beckman BS, Cleveland TE, McLachlan JA, Bhatnagar D, Wiese TE, Erhardt P, Burow ME. Glyceollin I enantiomers distinctly regulate ER-mediated gene expression. Steroids. 75: 870-8. PMID 20493896 DOI: 10.1016/J.Steroids.2010.05.007 |
0.761 |
|
| 2010 |
Antoon JW, Liu J, Ponnapakkam AP, Gestaut MM, Foroozesh M, Beckman BS. Novel D: -erythro N-octanoyl sphingosine analogs as chemo- and endocrine-resistant breast cancer therapeutics. Cancer Chemotherapy and Pharmacology. 65: 1191-5. PMID 20155475 DOI: 10.1007/S00280-009-1233-0 |
0.686 |
|
| 2010 |
Zimmermann MC, Tilghman SL, Boué SM, Salvo VA, Elliott S, Williams KY, Skripnikova EV, Ashe H, Payton-Stewart F, Vanhoy-Rhodes L, Fonseca JP, Corbitt C, Collins-Burow BM, Howell MH, Lacey M, ... ... Beckman BS, et al. Glyceollin I, a novel antiestrogenic phytoalexin isolated from activated soy. The Journal of Pharmacology and Experimental Therapeutics. 332: 35-45. PMID 19797619 DOI: 10.1124/Jpet.109.160382 |
0.764 |
|
| 2010 |
Rhodes LV, Muir SE, Elliott S, Guillot LM, Antoon JW, Penfornis P, Tilghman SL, Salvo VA, Fonseca JP, Lacey MR, Beckman BS, McLachlan JA, Rowan BG, Pochampally R, Burow ME. Adult human mesenchymal stem cells enhance breast tumorigenesis and promote hormone independence. Breast Cancer Research and Treatment. 121: 293-300. PMID 19597705 DOI: 10.1007/S10549-009-0458-2 |
0.673 |
|
| 2010 |
Antoon JW, White MD, Gestaut MM, Slaughter EM, Elliott S, Driver JL, Khalili HS, Smith CD, Burow ME, Beckman BS. Abstract 2537: The novel sphingosine kinase inhibitor ABC294640 blocks survival and tumorigenesis in chemo- And endocrine resistant breast cancer Cancer Research. 70: 2537-2537. DOI: 10.1158/1538-7445.Am10-2537 |
0.727 |
|
| 2010 |
White MD, Antoon JW, Meacham WD, Slaughter EM, Burow ME, Beckman BS. Abstract 1633: The sphingosine kinase inhibitor SKI-II blocks survival and MAPK signaling in human breast cancer in vitro Cancer Research. 70: 1633-1633. DOI: 10.1158/1538-7445.Am10-1633 |
0.736 |
|
| 2010 |
Gestaut MM, Antoon JW, Ponnapakam AP, J L, Burow ME, Foroozesh M, Beckman BS. Abstract 1031: Sphingolipid metabolism as a therapeutic target in chemotherapy resistant and hormone therapy resistant breast cancer Cancer Research. 70: 1031-1031. DOI: 10.1158/1538-7445.Am10-1031 |
0.7 |
|
| 2009 |
Antoon JW, Liu J, Gestaut MM, Burow ME, Beckman BS, Foroozesh M. Design, synthesis, and biological activity of a family of novel ceramide analogues in chemoresistant breast cancer cells. Journal of Medicinal Chemistry. 52: 5748-52. PMID 19694470 DOI: 10.1021/Jm9009668 |
0.705 |
|
| 2009 |
Meacham WD, Antoon JW, Burow ME, Struckhoff AP, Beckman BS. Sphingolipids as determinants of apoptosis and chemoresistance in the MCF-7 cell model system. Experimental Biology and Medicine (Maywood, N.J.). 234: 1253-63. PMID 19546354 DOI: 10.3181/0902-Mr-77 |
0.697 |
|
| 2009 |
Rees BB, Figueroa YG, Wiese TE, Beckman BS, Schulte PM. A novel hypoxia-response element in the lactate dehydrogenase-B gene of the killifish Fundulus heteroclitus. Comparative Biochemistry and Physiology. Part a, Molecular & Integrative Physiology. 154: 70-7. PMID 19439190 DOI: 10.1016/J.Cbpa.2009.05.001 |
0.305 |
|
| 2009 |
Boué SM, Tilghman SL, Elliott S, Zimmerman MC, Williams KY, Payton-Stewart F, Miraflor AP, Howell MH, Shih BY, Carter-Wientjes CH, Segar C, Beckman BS, Wiese TE, Cleveland TE, McLachlan JA, et al. Identification of the potent phytoestrogen glycinol in elicited soybean (Glycine max). Endocrinology. 150: 2446-53. PMID 19116342 DOI: 10.1210/En.2008-1235 |
0.437 |
|
| 2008 |
Zhou C, Nitschke AM, Xiong W, Zhang Q, Tang Y, Bloch M, Elliott S, Zhu Y, Bazzone L, Yu D, Weldon CB, Schiff R, McLachlan JA, Beckman BS, Wiese TE, et al. Proteomic analysis of tumor necrosis factor-alpha resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotype. Breast Cancer Research : Bcr. 10: R105. PMID 19087274 DOI: 10.1186/Bcr2210 |
0.682 |
|
| 2008 |
Bogatch M, Kreisman NR, Beckman BS. The heat shock protein 70 (Hsp70)/PI3-K/Akt/HIF/biologic pathway as a putative determinant of hypothermic preconditioning in neuroprotection Bioscience Hypotheses. 1: 203-208. DOI: 10.1016/J.Bihy.2008.07.004 |
0.341 |
|
| 2007 |
Tang Y, Zhao DY, Elliott S, Zhao W, Curiel TJ, Beckman BS, Burow ME. Epigallocatechin-3 gallate induces growth inhibition and apoptosis in human breast cancer cells through survivin suppression. International Journal of Oncology. 31: 705-11. PMID 17786300 DOI: 10.3892/Ijo.31.4.705 |
0.545 |
|
| 2007 |
Abboud ER, Coffelt SB, Figueroa YG, Zwezdaryk KJ, Nelson AB, Sullivan DE, Morris CB, Tang Y, Beckman BS, Scandurro AB. Integrin-linked kinase: a hypoxia-induced anti-apoptotic factor exploited by cancer cells. International Journal of Oncology. 30: 113-22. PMID 17143519 DOI: 10.3892/Ijo.30.1.113 |
0.485 |
|
| 2006 |
Salvo VA, Boué SM, Fonseca JP, Elliott S, Corbitt C, Collins-Burow BM, Curiel TJ, Srivastav SK, Shih BY, Carter-Wientjes C, Wood CE, Erhardt PW, Beckman BS, McLachlan JA, Cleveland TE, et al. Antiestrogenic glyceollins suppress human breast and ovarian carcinoma tumorigenesis. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 7159-64. PMID 17145841 DOI: 10.1158/1078-0432.Ccr-06-1426 |
0.458 |
|
| 2006 |
Duong BN, Elliott S, Frigo DE, Melnik LI, Vanhoy L, Tomchuck S, Lebeau HP, David O, Beckman BS, Alam J, Bratton MR, McLachlan JA, Burow ME. AKT regulation of estrogen receptor beta transcriptional activity in breast cancer. Cancer Research. 66: 8373-81. PMID 16951146 DOI: 10.1158/0008-5472.Can-05-3845 |
0.482 |
|
| 2005 |
Weldon CB, McKee A, Collins-Burow BM, Melnik LI, Scandurro AB, McLachlan JA, Burow ME, Beckman BS. PKC-mediated survival signaling in breast carcinoma cells: a role for MEK1-AP1 signaling. International Journal of Oncology. 26: 763-8. PMID 15703835 DOI: 10.3892/Ijo.26.3.763 |
0.703 |
|
| 2005 |
Frigo DE, Vigh KA, Struckhoff AP, Elliott S, Beckman BS, Burow ME, McLachlan JA. Xenobiotic-induced TNF-alpha expression and apoptosis through the p38 MAPK signaling pathway. Toxicology Letters. 155: 227-38. PMID 15603917 DOI: 10.1016/J.Toxlet.2004.09.008 |
0.443 |
|
| 2004 |
Williams CC, Allison JG, Vidal GA, Burow ME, Beckman BS, Marrero L, Jones FE. The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone. The Journal of Cell Biology. 167: 469-78. PMID 15534001 DOI: 10.1083/Jcb.200403155 |
0.45 |
|
| 2004 |
Weldon CB, Parker AP, Patten D, Elliott S, Tang Y, Frigo DE, Dugan CM, Coakley EL, Butler NN, Clayton JL, Alam J, Curiel TJ, Beckman BS, Jaffe BM, Burow ME. Sensitization of apoptotically-resistant breast carcinoma cells to TNF and TRAIL by inhibition of p38 mitogen-activated protein kinase signaling. International Journal of Oncology. 24: 1473-80. PMID 15138590 DOI: 10.3892/Ijo.24.6.1473 |
0.702 |
|
| 2004 |
Struckhoff AP, Bittman R, Burow ME, Clejan S, Elliott S, Hammond T, Tang Y, Beckman BS. Novel ceramide analogs as potential chemotherapeutic agents in breast cancer. The Journal of Pharmacology and Experimental Therapeutics. 309: 523-32. PMID 14742741 DOI: 10.1124/Jpet.103.062760 |
0.514 |
|
| 2004 |
Frigo DE, Tang Y, Beckman BS, Scandurro AB, Alam J, Burow ME, McLachlan JA. Mechanism of AP-1-mediated gene expression by select organochlorines through the p38 MAPK pathway. Carcinogenesis. 25: 249-61. PMID 14604893 DOI: 10.1093/Carcin/Bgh009 |
0.422 |
|
| 2003 |
Simstein R, Burow M, Parker A, Weldon C, Beckman B. Apoptosis, chemoresistance, and breast cancer: insights from the MCF-7 cell model system. Experimental Biology and Medicine (Maywood, N.J.). 228: 995-1003. PMID 14530507 DOI: 10.1177/153537020322800903 |
0.717 |
|
| 2002 |
Figueroa YG, Chan AK, Ibrahim R, Tang Y, Burow ME, Alam J, Scandurro AB, Beckman BS. NF-kappaB plays a key role in hypoxia-inducible factor-1-regulated erythropoietin gene expression. Experimental Hematology. 30: 1419-27. PMID 12482504 DOI: 10.1016/S0301-472X(02)00934-7 |
0.329 |
|
| 2002 |
Weldon CB, Scandurro AB, Rolfe KW, Clayton JL, Elliott S, Butler NN, Melnik LI, Alam J, McLachlan JA, Jaffe BM, Beckman BS, Burow ME. Identification of mitogen-activated protein kinase kinase as a chemoresistant pathway in MCF-7 cells by using gene expression microarray. Surgery. 132: 293-301. PMID 12219026 DOI: 10.1067/Msy.2002.125389 |
0.626 |
|
| 2001 |
Burow ME, Weldon CB, Tang Y, McLachlan JA, Beckman BS. Oestrogen-mediated suppression of tumour necrosis factor alpha-induced apoptosis in MCF-7 cells: subversion of Bcl-2 by anti-oestrogens. The Journal of Steroid Biochemistry and Molecular Biology. 78: 409-18. PMID 11738551 DOI: 10.1016/S0960-0760(01)00117-0 |
0.692 |
|
| 2001 |
Weldon CB, Burow ME, Rolfe KW, Clayton JL, Jaffe BM, Beckman BS. NF-κB-mediated chemoresistance in breast cancer cells Surgery. 130: 143-150. PMID 11490342 DOI: 10.1067/Msy.2001.115512 |
0.683 |
|
| 2001 |
Scandurro AB, Weldon CW, Figueroa YG, Alam J, Beckman BS. Gene microarray analysis reveals a novel hypoxia signal transduction pathway in human hepatocellular carcinoma cells. International Journal of Oncology. 19: 129-35. PMID 11408933 DOI: 10.3892/Ijo.19.1.129 |
0.399 |
|
| 2000 |
Burow ME, Weldon CB, Chiang TC, Tang Y, Collins-Burow BM, Rolfe K, Li S, McLachlan JA, Beckman BS. Differences in protein kinase C and estrogen receptor alpha, beta expression and signaling correlate with apoptotic sensitivity of MCF-7 breast cancer cell variants. International Journal of Oncology. 16: 1179-87. PMID 10811993 DOI: 10.3892/Ijo.16.6.1179 |
0.715 |
|
| 2000 |
Burow ME, Weldon CB, Melnik LI, Duong BN, Collins-Burow BM, Beckman BS, McLachlan JA. PI3-K/AKT regulation of NF-kappaB signaling events in suppression of TNF-induced apoptosis. Biochemical and Biophysical Research Communications. 271: 342-5. PMID 10799299 DOI: 10.1006/Bbrc.2000.2626 |
0.668 |
|
| 2000 |
Burow ME, Weldon CB, Collins-Burow BM, Ramsey N, McKee A, Klippel A, McLachlan JA, Clejan S, Beckman BS. Cross-talk between phosphatidylinositol 3-kinase and sphingomyelinase pathways as a mechanism for cell survival/death decisions. The Journal of Biological Chemistry. 275: 9628-35. PMID 10734114 DOI: 10.1074/Jbc.275.13.9628 |
0.669 |
|
| 2000 |
Godin DA, Fitzpatrick PC, Scandurro AB, Belafsky PC, Woodworth BA, Amedee RG, Beech DJ, Beckman BS. PH20: a novel tumor marker for laryngeal cancer. Archives of Otolaryngology--Head & Neck Surgery. 126: 402-4. PMID 10722016 DOI: 10.1001/Archotol.126.3.402 |
0.303 |
|
| 1999 |
Burow ME, Tang Y, Collins-Burow BM, Krajewski S, Reed JC, McLachlan JA, Beckman BS. Effects of environmental estrogens on tumor necrosis factor alpha-mediated apoptosis in MCF-7 cells. Carcinogenesis. 20: 2057-61. PMID 10545406 DOI: 10.1093/Carcin/20.11.2057 |
0.46 |
|
| 1999 |
Ohigashi T, Mallia CS, McGary E, Scandurro AB, Rondon I, Fisher JW, Beckman BS. Protein kinase C alpha protein expression is necessary for sustained erythropoietin production in human hepatocellular carcinoma (Hep3B) cells exposed to hypoxia. Biochimica Et Biophysica Acta. 1450: 109-18. PMID 10354503 DOI: 10.1016/S0167-4889(99)00029-4 |
0.392 |
|
| 1999 |
Mallia CM, Aguirre V, McGary E, Tang Y, Scandurro AB, Liu C, Noguchi CT, Beckman BS. Protein kinase calpha is an effector of hexamethylene bisacetamide-induced differentiation of Friend erythroleukemia cells. Experimental Cell Research. 246: 348-54. PMID 9925750 DOI: 10.1006/Excr.1998.4312 |
0.395 |
|
| 1998 |
Burow ME, Weldon CB, Tang Y, Navar GL, Krajewski S, Reed JC, Hammond TG, Clejan S, Beckman BS. Differences in susceptibility to tumor necrosis factor alpha-induced apoptosis among MCF-7 breast cancer cell variants. Cancer Research. 58: 4940-6. PMID 9810003 |
0.645 |
|
| 1998 |
Kelly ML, Tang Y, Rosensweig N, Clejan S, Beckman BS. Granulocyte-macrophage colony-stimulating factor rescues TF-1 leukemia cells from ionizing radiation-induced apoptosis through a pathway mediated by protein kinase Calpha. Blood. 92: 416-24. PMID 9657740 DOI: 10.1182/Blood.V92.2.416.414K01_416_424 |
0.415 |
|
| 1997 |
Mallia CM, Smith M, Clejan S, Beckman BS. Erythropoietin stimulates nuclear localization of diacylglycerol and protein kinase C beta II in B6SUt.EP cells. Journal of Lipid Mediators and Cell Signalling. 17: 135-50. PMID 9524923 DOI: 10.1016/S0929-7855(97)00027-8 |
0.396 |
|
| 1996 |
Qin Y, Tang Y, Schally A, Beckman B. Dexniguldipine hydrochloride inhibits growth of human pancreatic adenocarcinoma cells and expression of protein kinase C isoforms alpha and zeta. International Journal of Oncology. 8: 15-20. PMID 21544325 DOI: 10.3892/Ijo.8.1.15 |
0.418 |
|
| 1996 |
Klotz DM, Beckman BS, Hill SM, McLachlan JA, Walters MR, Arnold SF. Identification of environmental chemicals with estrogenic activity using a combination of in vitro assays. Environmental Health Perspectives. 104: 1084-9. PMID 8930550 DOI: 10.1289/Ehp.961041084 |
0.395 |
|
| 1996 |
Patterson KK, Beckman BS, Klotz DM, Mallia CM, Jeter JR. Dexniguldipine hydrochloride, a protein-kinase-C-specific inhibitor, affects the cell cycle, differentiation, P-glycoprotein levels, and nuclear protein phosphorylation in Friend erythroleukemia cells. Journal of Cancer Research and Clinical Oncology. 122: 465-75. PMID 8698746 DOI: 10.1007/Bf01187158 |
0.407 |
|
| 1996 |
Clejan S, Mallia C, Vinson D, Dotson R, Beckman BS. Erythropoietin stimulates G-protein-coupled phospholipase D in haematopoietic target cells. The Biochemical Journal. 314: 853-60. PMID 8615780 DOI: 10.1042/Bj3140853 |
0.332 |
|
| 1995 |
Qin Y, Tang Y, Schally AV, Beckman BS. Dexniguldipine Hydrochloride Inhibits Growth Of Human Ht-29 Colon-Carcinoma Cells And Expression Of Protein-Kinase-C-Delta And Protein-Kinase-C-Zeta International Journal of Oncology. 7: 1073-1077. PMID 21552934 DOI: 10.3892/Ijo.7.5.1073 |
0.361 |
|
| 1995 |
Clejan S, Dotson RS, Ide CF, Beckman BS. Coordinated effects of electromagnetic field exposure on erythropoietin-induced activities of phosphatidylinositol-phospholipase C and phosphatidylinositol 3-kinase. Cell Biochemistry and Biophysics. 27: 203-25. PMID 9279457 DOI: 10.1007/Bf02738110 |
0.416 |
|
| 1995 |
Mallia CM, Jeter JR, Fields AP, Wilson RB, Beckman BS. Protein kinase C beta from Friend erythroleukemia cells is associated with chromatin and DNA. Molecular and Cellular Biochemistry. 151: 107-11. PMID 8569755 DOI: 10.1007/Bf01322332 |
0.328 |
|
| 1995 |
Rondon IJ, Scandurro AB, Wilson RB, Beckman BS. Changes in redox affect the activity of erythropoietin RNA binding protein. Febs Letters. 359: 267-70. PMID 7867812 DOI: 10.1016/0014-5793(95)00066-I |
0.317 |
|
| 1995 |
Mason-Garcia M, Harlan RE, Mallia C, Jeter JR, Steinberg HB, Fermin C, Beckman BS. Interleukin-3 or erythropoietin induced nuclear localization of protein kinase C beta isoforms in hematopoietic target cells. Cell Proliferation. 28: 145-55. PMID 7734624 DOI: 10.1111/J.1365-2184.1995.Tb00063.X |
0.349 |
|
| 1995 |
Gogu SR, Beckman BS, Wilson RB, Agrawal KC. Inhibitory effects of zidovudine in erythroid progenitor cells. Reversal with a combination of erythropoietin and interleukin-3. Biochemical Pharmacology. 50: 413-9. PMID 7646543 DOI: 10.1016/0006-2952(95)00134-L |
0.385 |
|
| 1993 |
Silliman CC, Beckman BS, Jeter JR. Changes in protein kinase activity within 30 min of induced differentiation in Friend erythroleukemia cells. Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire. 71: 1-6. PMID 8392352 DOI: 10.1139/O93-001 |
0.386 |
|
| 1993 |
Nakashima J, Brookins J, Beckman B, Ohigashi T, Fisher JW. In vivo and in vitro erythropoietin activities in cultures of a hepatocellular carcinoma cell line. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 203: 84-91. PMID 8386383 DOI: 10.3181/00379727-203-43577 |
0.314 |
|
| 1992 |
Beckman BS. Nuclear protein kinase C activity is decreased in Friend erythroleukemia cells induced to differentiate. Experimental Hematology. 20: 324-7. PMID 1568447 |
0.327 |
|
| 1992 |
Beckman BS, Despinasse BP, Spriggs L. Actions of lipoxins A4 and B4 on signal transduction events in Friend erythroleukemia cells. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 201: 169-73. PMID 1409732 DOI: 10.3181/00379727-201-43495 |
0.36 |
|
| 1992 |
Mason-Garcia M, Clejan S, Tou JS, Beckman BS. Signal transduction by the erythropoietin receptor: evidence for the activation of phospholipases A2 and C. The American Journal of Physiology. 262: C1197-203. PMID 1317100 DOI: 10.1152/Ajpcell.1992.262.5.C1197 |
0.368 |
|
| 1991 |
Mason-Garcia M, Beckman BS. Signal transduction in erythropoiesis. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 5: 2958-64. PMID 1752362 DOI: 10.1096/Fasebj.5.14.1752362 |
0.383 |
|
| 1991 |
Nakashima J, Brookins J, Beckman B, Fisher JW. Increased erythropoietin secretion in human hepatoma cells by N6-cyclohexyladenosine. The American Journal of Physiology. 261: C455-60. PMID 1653522 DOI: 10.1152/Ajpcell.1991.261.3.C455 |
0.351 |
|
| 1990 |
Mason-Garcia M, Weill CL, Beckman BS. Rapid activation by erythropoietin of protein kinase C in nuclei of erythroid progenitor cells. Biochemical and Biophysical Research Communications. 168: 490-7. PMID 2334419 DOI: 10.1016/0006-291X(90)92348-4 |
0.395 |
|
| 1990 |
Beckman BS, Mason-Garcia M, Martinez MI, Fermin C. Enhanced expression of the β II subspecies of protein kinase C in differentiating erythroleukemia cells Experimental Cell Research. 191: 319-322. PMID 2257884 DOI: 10.1016/0014-4827(90)90021-2 |
0.344 |
|
| 1990 |
Ueno M, Rondon I, Beckman B, Brookins J, Nakashima J, Cole FE, Fisher JW. Increased secretion of erythropoietin in human renal carcinoma cells in response to atrial natriuretic factor. The American Journal of Physiology. 259: C427-31. PMID 2169194 DOI: 10.1152/Ajpcell.1990.259.3.C427 |
0.336 |
|
| 1990 |
Postoak D, Nystuen L, King L, Ueno M, Beckman BS. 15-Lipoxygenase products of arachidonate play a role in proliferation of transformed erythroid cells. The American Journal of Physiology. 259: C849-53. PMID 2124416 DOI: 10.1152/Ajpcell.1990.259.6.C849 |
0.344 |
|
| 1989 |
Beckman BS, Balin AK, Allen RG. Superoxide dismutase induces differentiation of Friend erythroleukemia cells. Journal of Cellular Physiology. 139: 370-6. PMID 2715192 DOI: 10.1002/Jcp.1041390220 |
0.335 |
|
| 1989 |
Gogu SR, Beckman BS, Rangan SR, Agrawal KC. Increased therapeutic efficacy of zidovudine in combination with vitamin E. Biochemical and Biophysical Research Communications. 165: 401-7. PMID 2590237 DOI: 10.1016/0006-291X(89)91084-X |
0.318 |
|
| 1989 |
Ueno M, Seferynska I, Beckman B, Brookins J, Nakashima J, Fisher JW. Enhanced erythropoietin secretion in hepatoblastoma cells in response to hypoxia. The American Journal of Physiology. 257: C743-9. PMID 2552819 DOI: 10.1152/Ajpcell.1989.257.4.C743 |
0.323 |
|
| 1988 |
Beckman B, Nystuen L. Comparative effects of inhibitors of arachidonic acid metabolism on erythropoiesis. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 31: 23-6. PMID 3131779 DOI: 10.1016/0952-3278(88)90160-3 |
0.318 |
|
| 1987 |
Beckman BS, Mason-Garcia M, Nystuen L, King L, Fisher JW. The action of erythropoietin is mediated by lipoxygenase metabolites in murine fetal liver cells. Biochemical and Biophysical Research Communications. 147: 392-8. PMID 3115260 DOI: 10.1016/S0006-291X(87)80134-1 |
0.324 |
|
| 1987 |
Beckman BS, Kopfler W, Koury P, Jeter JR. Effect of aphidicolin on Friend erythroleukemia cell maturation. Experimental Cell Research. 169: 223-32. PMID 3102267 DOI: 10.1016/0014-4827(87)90240-0 |
0.352 |
|
| 1984 |
Pincus SM, Beckman BS, George WJ. Inhibition of dimethylsulfoxide-induced differentiation in Friend erythroleukemic cells by diacylglycerols and phospholipase C. Biochemical and Biophysical Research Communications. 125: 491-9. PMID 6596101 DOI: 10.1016/0006-291X(84)90567-9 |
0.374 |
|
| 1984 |
Hagiwara M, Chen I, McGonigle R, Beckman B, Kasten F, Fisher J. Erythropoietin production in a primary culture of human renal carcinoma cells maintained in nude mice Blood. 63: 828-835. DOI: 10.1182/Blood.V63.4.828.Bloodjournal634828 |
0.302 |
|
| 1982 |
Beckman B, Anderson WF, Beltran G, Chen I, Fisher JW. Mixed myeloid-Lymphoid colonies in a patient with polycythemia vera. American Journal of Hematology. 12: 419-23. PMID 7114054 DOI: 10.1002/Ajh.2830120414 |
0.321 |
|
| 1980 |
Beckman B, Mirand E, Fisher JW. Effects of beta adrenergic agents and prostaglandin E1 on erythroid colony (CFU-E) growth and cyclic AMP formation in Friend erythroleukemic cells. Journal of Cellular Physiology. 105: 355-61. PMID 6257732 DOI: 10.1002/Jcp.1041050218 |
0.305 |
|
| Show low-probability matches. |